Shi, Wenzai
Wang, Yiming
Chen, Shuohua
Wei, Pengcheng
Ma, Delin
Zhu, Jiye
Zhang, Qingsong
Li, Zhao
Funding for this research was provided by:
Peking University International Hospital Research Grant (YN2023QN07)
Capital Health Research and Development of Special Fund (2022-2-4084)
Article History
Received: 29 October 2024
Accepted: 11 March 2025
First Online: 20 March 2025
Declarations
:
: This study obtained ethical approval from the ethics committees of Kailuan General Hospital and Peking University People’s Hospital, and it adhered to the principles outlined in the Declaration of Helsinki. Written informed consent was obtained from participants or their legal representatives. The Kailuan Study was retrospectively registered in the Chinese Clinical Trial Register on February 12, 2020 (ChiCTR2000029767; ).
: The manuscript’s guarantor affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
: The authors declare no competing interests.